Fast delivery D-Glucuronic Acid Lactone - LCZ696 Intermediate CAS 1426129-50-1 Purity ≥98.0% (HPLC) e.e ≥99.0% (R)-tert-Butyl (1-([1,1-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

We emphasize advancement and introduce new products and solutions into the market each year for Molecular Weight 104.1, 125971-94-0, Solifenacin Succinate CAS 242478-38-2, We welcome new and old customers from all walks of life to contact us for future business relationships and mutual success!
Fast delivery D-Glucuronic Acid Lactone - LCZ696 Intermediate CAS 1426129-50-1 Purity ≥98.0% (HPLC) e.e ≥99.0% (R)-tert-Butyl (1-([1,1-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Commercial Supply LCZ696 (CAS: 936623-90-4) Related Intermediates:
(R)-tert-Butyl (1-([1,1-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate CAS: 1426129-50-1
(R,E)-5-(1,1′-biphenyl-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid CAS: 1012341-48-8
(2R,4S)-5-(1,1′-biphenyl-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid CAS: 1012341-50-2
(2R,4S)-ethyl 5-(1,1′-biphenyl-4-yl)-4-amino-2-methylpentanoate HCl CAS: 149690-12-0
AHU-377 (hemicalcium salt) CAS: 1369773-39-6
AHU-377; Sacubitril CAS: 149709-62-6
LCZ696; Entresto; Sacubitril mixture with Valsartan CAS: 936623-90-4

Chemical Name (R)-tert-Butyl (1-([1,1-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate
Synonyms LCZ696 Intermediate
CAS Number 1426129-50-1
CAT Number RF-PI169
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C20H25NO3
Molecular Weight 327.42
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Powder
Purity / Analysis Method ≥98.0% (HPLC)
Enantiomeric Excess e.e: ≥99.0%
Moisture (K.F) ≤1.0%
Related Substances A ≤1.0% (RRT=0.5)  A=(R)-3-([1,1'-biphenyl]-4-yl)-2-aminopropan-1-ol
Related Substances B ≤1.0% (RRT=0.85) B=Triphenylphosphine oxide
Other Substances ≤1.0%
Total Impurities ≤2.0%
Test Standard Enterprise Standard
Usage Intermediate of LCZ696 (CAS: 936623-90-4) in the treatment of HFrEF

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1
2

Manufacturer with High Purity and Stable Quality
Commercial Supply LCZ696 (CAS: 936623-90-4) Related Intermediates:
(R)-tert-Butyl (1-([1,1-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate CAS: 1426129-50-1
(R,E)-5-(1,1′-biphenyl-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid CAS: 1012341-48-8
(2R,4S)-5-(1,1′-biphenyl-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid CAS: 1012341-50-2
(2R,4S)-ethyl 5-(1,1′-biphenyl-4-yl)-4-amino-2-methylpentanoate HCl CAS: 149690-12-0
AHU-377 (hemicalcium salt) CAS: 1369773-39-6
AHU-377; Sacubitril CAS: 149709-62-6
LCZ696; Entresto; Sacubitril mixture with Valsartan CAS: 936623-90-4

LCZ696 a drug developed by Novartis Pharmaceutical of the United States for the treatment of heart failure. Heart failure is a life-threatening disease. The patient’s heart cannot pump enough blood to supply the body, and appear the symptoms of dyspnea, fatigue and fluid retention slowly, then gradually increased, significantly affect the quality of life. LCZ696 is a dual-acting angiotensin-receptor enkephalinase inhibitor that has a unique mechanism that is thought to reduce the strain of failing hearts. LCZ696 can enhance the body’s natural defense against heart failure, as well as increase the level of natriuretic peptides and other endogenous vasoactive peptides, and inhibit the renin-angiotensin-aldosterone system (RAAS). LCZ696 has combined with Novartis’s Hypertension Medication (Diovan, generic name: valsartan) and the experimental drug AHU-377. AHU377 blocks the mechanism of the two peptides responsible for lowering blood pressure. Diovan improves vasodilatation and stimulates the body to excrete sodium and water. LCZ696 is an experimental drug developed for the treatment of patients with Heart Failure with reduced Ejection Fraction (HFrEF). LCZ696, composed of valsartan and sacubitril in a 1: 1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for the treatment of hypertension and heart failure.


Product detail pictures:

Fast delivery D-Glucuronic Acid Lactone - LCZ696 Intermediate CAS 1426129-50-1 Purity ≥98.0% (HPLC) e.e ≥99.0% (R)-tert-Butyl (1-([1,1-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate – Ruifu detail pictures


Related Product Guide:

We keep on with the basic principle of "quality to start with, support very first, continuous improvement and innovation to meet the customers" for your management and "zero defect, zero complaints" as the quality objective. To great our service, we offer the items with all the superior top quality at the reasonable selling price for Fast delivery D-Glucuronic Acid Lactone - LCZ696 Intermediate CAS 1426129-50-1 Purity ≥98.0% (HPLC) e.e ≥99.0% (R)-tert-Butyl (1-([1,1-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate – Ruifu , The product will supply to all over the world, such as: Sydney, Guatemala, Canada, Honest to every customers are our requested! First-class serve, best quality, best price and fastest delivery date is our advantage! Give every customers good serve is our tenet! This makes our company get the favour of customers and support! Welcome all over the world customers send us enquiry and looking forward your good co-operation !Make sure you your inquiry for more details or request for dealership in selected regions.
  • This enterprise in the industry is strong and competitive, advancing with the times and develop sustainable, we are very pleased to have a opportunity to cooperate!
    5 Stars By Jean from United States - 2017.11.01 17:04
    The goods we received and the sample sales staff display to us have the same quality, it is really a creditable manufacturer.
    5 Stars By Alma from Nepal - 2018.05.22 12:13
    Write your message here and send it to us